Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial — Anthony B. El-Khoueiry (2017) | RDL Network
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Ignacio Melero, Bruno Sangro, Thomas Cheung Yau, Chiun Hsu, Masatoshi Kudo, Todd S. Crocenzi, Tae‐You Kim, Su Pin Choo, Jörg Trojan, Tim Meyer, Theodore H. Welling, Winnie Yeo, Akhil Chopra, Jeffrey Anderson, Christine Marie Dela Cruz, Lixin Lang, Jaclyn Neely, Hao Tang, Anthony B. El-Khoueiry
Bruno Sangro, Ignacio Melero, Thomas Cheung Yau, Chiun Hsu, Masatoshi Kudo, Todd S. Crocenzi, Tae‐You Kim, Su Pin Choo, Jörg Trojan, Tim Meyer, Yoon‐Koo Kang, Jeffrey Anderson, Christine Marie Dela Cruz, Lixin Lang, Jaclyn Neely, Anthony B. El-Khoueiry
Thomas Yau, Joong‐Won Park, Richard S. Finn, Ann‐Lii Cheng, Philippe Mathurin, Julien Edeline, Masatoshi Kudo, James J. Harding, Philippe Merle, Olivier Rosmorduc, Lucjan Wyrwicz, Eckart Schott, Su Pin Choo, Robin Kate Kelley, Wolfgang Sieghart, Éric Assenat, Renata Zaucha, Junji Furuse, Ghassan K. Abou‐Alfa, Anthony B. El-Khoueiry, Ignacio Melero, Damir Begic,
Bruno Sangro, Aiwu Ruth He, Thomas Yau, Chiun Hsu, Yoon‐Koo Kang, Tae‐You Kim, Armando Santoro, Ignacio Melero, Masatoshi Kudo, M. Ho, Ana Matilla, Francesco Tovoli, Jennifer J. Knox, Bassel F. El‐Rayes, Mirelis Rivera Acosta, Jaclyn Neely, Yun Shen, Marina Tschaika, Anthony El-Khoureiry
Ignacio Melero, Bruno Sangro, Thomas Yau, Chih‐Hung Hsu, Masatoshi Kudo, Todd S. Crocenzi, T.-Y. Kim, Su Pin Choo, Jörg Trojan, Tim Meyer, T.H. Welling, Winnie Yeo, Arun Chopra, Jeffrey Anderson, C.l.a. De Cruz, L. Láng, Jaclyn Neely, Anthony B. El-Khoueiry
Discussion(0)
No comments yet. Be the first to comment.